Release From Glomerular Overload by the Addition of Low-dose Thiazide in Patients With Angiotensin Receptor Blocker-Resistant Hypertension

Publisher： Karger

E-ISSN： 1423-0143|37|6|521-530

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.37, Iss.6, 2013-11, pp. : 521-530

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and Tolerability of High-Dose Angiotensin Receptor Blocker Therapy in Patients with Chronic Kidney Disease: A Pilot Study

By  

American Journal of Nephrology, Vol. 24, Iss. 3, 2004-07 ,pp. : 340-345

Karger

Access to resources Recommend Favorite

Effect of Valsartan, an Angiotensin II AT1 Receptor Blocker, on the Glomerular Fibrosis of IgA Nephropathy in ddY Mice

By  

Nephron, Vol. 86, Iss. 3, 2000-11 ,pp. : 374-375

Karger

Access to resources Recommend Favorite

Prepubertal Treatment with Angiotensin Receptor Blocker Causes Partial Attenuation of Hypertension and Renal Damage in Adult Dahl Salt-Sensitive Rats

By  

Nephron, Vol. 91, Iss. 4, 2002-07 ,pp. : 710-718

Karger

Access to resources Recommend Favorite

Effect of Angiotensin II Receptor Blocker on Plasma Levels of TGF-β1 and Interstitial Fibrosis in Hypertensive Kidney Transplant Patients

By  

American Journal of Nephrology, Vol. 23, Iss. 5, 2003-09 ,pp. : 300-306

Karger

Access to resources Recommend Favorite

Impact of Angiotensin II Receptor Blocker on Plasma Levels of Adiponectin and Advanced Oxidation Protein Products in Peritoneal Dialysis Patients

By  

Blood Purification, Vol. 24, Iss. 5-6, 2006-12 ,pp. : 445-450

Karger

Access to resources Recommend Favorite